4
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic effect of paclitaxel (taxol) either alone or in combination with irradiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro

Pages 225-231 | Published online: 03 Jul 2009

  • CALDAS, C. and McGUIRE III, W. P., 1993, Paclitaxel (TAXOL) therapy in ovarian carcinoma. Seminars in Oncology, 20, 50-55.
  • CHOY, H., RODRIGUEZ, F. F., KOESTER, S., HILSENBBCK, S. and VON HOFF, D. D., 1993, Investigation of taxol as a potential radiation sensitizer. Cancer, 71, 3774-3778.
  • ETTINGER, D. S., 1993, Taxol in the treatment of lung cancer. Journal of the National Cancer Institute Monographs, 15, 177-179.
  • FORASTIERE, A. A., 1993, Use of paclitaxel (TAXOL) in squamous cell carcinoma of the head and neck. Seminars in Oncology, 20, 56-60.
  • OAN, Y., WIENTIES, M. G., SCHULLER, D. E. and AU, J. L., 1996, Pharmacodynamics of taxol in human head and neck tumors. Cancer Research, 56, 2086-2093.
  • GANGEMI, R. M. R., TISO, M., MARCHETTI, C., SEVERI, A. B. and FABBI, M., 1995, Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed Cell death. Cancer Chemotherapy Pharmacology, 36, 385-392.
  • GEARD, C. R., JONES, J. M. and SCHIFF, P. B., 1993, Taxol and radiation. Journal of the National Cancer Institute Monographs, 15, 89-94.
  • GEARD, C. R. and JONES, J. M., 1994, Radiation and taxol effects on synchronized human cervical carcinoma cells. International Journal of Radiation Oncology, Biology, and Physics, 29, 565-569.
  • GREGORY, R. E. and DELISA, A. F., 1993, Paclitaxel: a new antineoplastic agent for refractory ovarian cancer, clinical Pharmacy, 12, 401-415.
  • HALDAR, S., CHINTAPALLI, J. and CROCE, C. M., 1996, Taxol induces bcl-2 phosphorylation and death of prostate Cancer Cells. Cancer Research, 56, 1253-1255.
  • HOLMES, F. A., WALTERS, R. S., THERIAULT, R. L., FORMAN, A. D., NEWTON, L. K., RABER, M. N., BUZDAR, A. U., FRYE, D. K. and HORTOBAGYI, G. N., 1991, Phase II trial of taxol, an active drug in the treatment of metastatic breast Cancer. Journal of National Cancer Institute, 83, 1797-1805.
  • HORWITZ, S. B., COHEN, D., RAO, S., RINGEL, I., SHEN, H. and YANG, C. H., 1993, Taxol: mechanisms of action and resistance. Journal of the National Cancer Institute Monographs, 15, 55-61.
  • LEGHA, S. S., RING, S., PAPADOPOULOS, N., RABER, M. and BENJAMIN, R. S., 1990, A phase II trial of taxol in metastatic melanoma. Cancer, 65, 2478-2481.
  • LIEBMANN, J., COOK, J. A., FISHER, J., TEAGUE, D. and MITCHELL, J. B., 1994, in vitro studies of taxol as a radiation sensitizer in human tumor Cells. Journal of the National Cancer Institute, 86, 441-446.
  • LIEBMANN, J. E., COOK, J. A., LIPSCHULTZ, C., TEAGUE, D., FISHER, J. and MITCHELL, J. B., 1993, Cytotoxic studies of paclitaxel (Taxol) In human tumour cell lines. British Journal of Cancer, 68, 1104-1109.
  • LILENBAUM, R. C. and GREEN, M. R., 1993, Novel chemotherapeutic agents in the treatment of non-small-cell lung Cancel. Journal of Clinical Oncology, 11, 1391-1402.
  • LOPES, N. M., ADAMS, E. G., PITTS, T. W. and BHUYAN, B. K., 1993, Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer chemotherapy and Pharmacology, 32, 235-242.
  • MILAS, L., HUNTER, N. R., KURDOGLU, B., MASON, K. A., MEYN, R. E. and PETERS, L. J., 1995b, Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated With taxol. Cancer Chemotherapy Pharmacology, 35, 297-303.
  • MILAS, L., HUNTER, N. R., MASON, K. A., KURDOGLU, B. and PETERS, L. J., 1994, Enhancement of tumor radioresponse of a murine mammary carcinoma by Paclitaxel. Cancer Research, 54, 3506-3510.
  • MILAS, L., HUNTER, N. R., MASON, K. A., MILROSS, C. G., SAITO, Y. and PETERS, L. J., 1995a, Role of reoxygenation in induction of enhancement of tumor radioresponse by Paclitaxel. Cancer Research, 55, 3564-3568.
  • MILAS, L., SAITO, Y., HUNTER, N. R., MILROSS, C. G. and MASON, K. A., 1996, Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Radiotherapy and Oncology, 40, 163-170.
  • MILROSS, C. G., MASON, K. A., HUNTER, N. R., CHUNG, W., PETERS, L. J. and MILAS, L., 1996, Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. Journal of the National Cancer Institute, 88, 1308-1314.
  • MINARIK, L. and HALL, E. J., 1994, Taxol in combination with acute and low dose rate irradiation. Radiotherapy and Oncology, 32, 124-128.
  • MITSUHASHI, N., TAKAHASHI, T., NOZAKI, M., MATSUMOTO, H., SAKURAI, H., TAKAHASHI, M. and NIIBE, H., 1993, Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing a-fetoprotein, with potential for lymphatic metastasis. Japanese Journal of Cancer Research, 84, 1287-1291.
  • MITSUHASHI, N., TAKAHASHI, T., SAKURAI, H. et al., 1996, A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological Changes, especially apoptosis. International Journal of Radiation Biology, 69, 329-336.
  • NAKAMOTO, S., MITSUHASHI, N., TAKAHASHI, T., SAKURAI, H. and NIIBE, H., 1996, An interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. International Journal of Radiation Biology, 70, 747-753.
  • NOZAKI, M., 1992, Biological and histopathological characteristics of experimental yolk sac tumors developed by fetectomy and their usefulness in radiotherapeutic experiments. Journal of the Japanese Society for Therapeutic Radiology and Oncology, 4, 33-43.
  • PULKKINEN, J. O., ELOMAA, L., JOENSUU, H., MARTIKAINEN, P., SERVOMAA, K. and GRENMAN, R., 1996, Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck Cancer. Journal of Cancer Research Clinical Oncology, 122, 214-218.
  • STEREN, A., SEVIN, B. U., PERRAS, J., ANGIOLI, R., NGUYEN, H., GUBRRA, L., KOECHLI, O. and AVERETTE, H. E., 1993, Taxol sensitizes human ovarian cancer cells to radiation. Gynecologic Oncology, 48, 252-258.
  • STROMBERG, J. S., LEE, Y. J., ARMOUR, E. P., MARTINEZ, A. A. and CORRY, P. M., 1995, Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer, 75, 2262-2268.
  • TISHLER, R. B., GEARD, C. R., HALL, E. J. and SCHIFF, P. B., 1992a, Taxol sensitizes human astrocytoma cells to radiation. Cancer Research, 52, 3495-3497.
  • TISHLER, R. B., LAMPPU, D. M, PARK, S. and PRICE, B. D., 1995. Microtubule-active drugs Taxol, Vinblastine, and Nocodazole increase the levels of transcriptionally active p53. Cancer Research, 55, 6021-6025.
  • TISHLER, R. B., SCHIFF, P. B., GEARD, C. R. and HALL, E. J., 1992b, Taxol: a novel radiation sensitizer. International Journal of Radiation Oncology, Biology, Physics, 22, 613-617.
  • VASEY, P. A., JONES, N. A., JENKINS, S., DIVE, C. and BROWN, R., 1996, Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Molecular Pharmacology, 50, 1536-1540.
  • WAHL, A. F., DONALDSON, K. L., FAIRCHILD, C., LEE, F. Y. F., FOSTER, S. A., DEMERS, G. W. and GALLOWAY, D. A., 1996. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nature Medicine, 2, 72-79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.